$21.17
-0.150 (-0.704%)
At Close: Jul 31, 2026
17 Ideal Pre-Crash Recovery December Divi-Dogs
04:55pm, Thursday, 30'th Nov 2023
September-October, 2023, Barron's, Bloomberg, and Fortune analysts and reporters combined to list five sets of stocks sorted as “Recovery Bets.” Those five articles revealed 53 equities, with 42 p
Sabra Health Care REIT, Inc. (SBRA) Q3 2023 Earnings Call Transcript
08:32pm, Tuesday, 07'th Nov 2023
Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q3 2023 Earnings Conference Call November 7, 2023 1:00 PM ET Company Participants Lukas Hartwich - Senior Vice President, Finance Rick Matros - Chief Execut
Sabra (SBRA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
07:33pm, Monday, 06'th Nov 2023
While the top- and bottom-line numbers for Sabra (SBRA) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare
Nursing Home REITs: The Surprise Heroes of High Yield Investing
09:59am, Thursday, 28'th Sep 2023
Yes, it may sound preposterous, but take a look at some equities you probably aren't familiar with: Omega Healthcare Investors NYSE: OHI, Sabra Health Care REIT NASDAQ: SBRA, and LTC Properties NYSE:
Sabra Health Care: A 9% Yielding Healthcare REIT
03:56am, Wednesday, 20'th Sep 2023
Sabra Health Care REIT has defied our expectations and stabilized its funds from operations over the last 9 months. The company has seen occupancy gains in senior housing-leased and behavioral health
5 REITs That Will Likely Cut Their Dividends
08:05am, Thursday, 24'th Aug 2023
REITs are cheap and undervalued. But some REIT dividends are risky. I highlight 5 REITs that I think are likely to cut their dividends.
Sabra (SBRA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
09:09pm, Monday, 07'th Aug 2023
Although the revenue and EPS for Sabra (SBRA) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street est
Sabra Healthcare (SBRA) Q2 FFO Meet Estimates
06:54pm, Monday, 07'th Aug 2023
Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.34 per share, in line with the Zacks Consensus Estimate. This compares to FFO of $0.39 per share a year ago.
Sabra Health Care REIT: 9.6% Yield, Price And Prognosis Improving
03:42am, Monday, 17'th Jul 2023
Rose's Income Garden Portfolio owns Sabra Health Care, a healthcare facility real estate investment trust, which offers a 9.6% dividend yield. Sabra owns or runs 396 real estate properties across the
3 REITs To Sell Before They Do Your Portfolio In
09:56am, Monday, 10'th Jul 2023
Much like the rest of the real estate market, real estate investment trusts (REITs) have their ups and downs. They are a popular way to get into the business without having to deal directly with prope
Sabra Health Care: Risks Outweigh The Benefits
01:33am, Tuesday, 06'th Jun 2023
Sabra Health Care REIT operates nursing facilities and senior housing facilities. The REIT has low occupancy and was hit hard during Covid resulting in a low FFO multiple. I present my analysis that l
7 REITs to Sell Before They Crumble Under Pressure
04:27pm, Sunday, 04'th Jun 2023
Rising interest rates and the economic slowdown have already weighed on real estate investment trusts (REITs). Unfortunately, there are still plenty of REITs to sell before they drop even further.
Sell Alert: 2 REITs Getting Risky
08:05am, Thursday, 01'st Jun 2023
I am bullish on some REITs, but not all of them. Some REITs are overpriced. Others are risky. We highlight two REITs that we have sold in recent years.
Sabra Health Care: The Reward Doesn't Justify The Risks
06:07am, Thursday, 25'th May 2023
Sabra is a skilled nursing and senior housing provider which has struggled with occupancy since the pandemic started. Occupancy is improving slowly, but tenant coverage remains extremely tight signifi
Sabra (SBRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
09:15pm, Wednesday, 03'rd May 2023
The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Sign In
Buy SBRA